The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).
Epistemonikos ID: b1d4994c3ca38b45a89e665d1fa5de34aa61966e
First added on: Dec 12, 2020